Ecstasy and neurodegeneration. ...such as ketamine.
Shewan
D
D
Dalgarno
P
P
D015104:3,4-Methylenedioxyamphetamine / Q000009:adverse effects / Q000031:analogs & derivatives; D015198:Designer Drugs / Q000009:adverse effects; D004340:Drug Contamination; D004809:Ephedrine / Q000032:analysis; D006213:Hallucinogens; D006801:Humans; D007649:Ketamine / Q000032:analysis; D019966:Substance-Related Disorders; D013607:Tablets / Q000032:analysis
D015198:Designer Drugs; D006213:Hallucinogens; D013607:Tablets; D015104:3,4-Methylenedioxyamphetamine; D007649:Ketamine; D004809:Ephedrine; C051800:3,4-methylenedioxyethamphetamine